Profile data is unavailable for this security.
About the company
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
- Revenue in USD (TTM)36.35m
- Net income in USD-31.68m
- Incorporated2019
- Employees210.00
- LocationAlpha Teknova Inc2451 Bert DriveHOLLISTER 95023United StatesUSA
- Phone+1 (831) 637-1100
- Fax+1 (845) 818-3588
- Websitehttps://www.teknova.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OraSure Technologies, Inc. | 224.26m | 11.37m | 284.20m | 638.00 | 25.30 | 0.6678 | 11.61 | 1.27 | 0.1506 | 0.1506 | 3.01 | 5.71 | 0.4862 | 2.64 | 5.58 | 351,509.40 | 2.72 | 0.7238 | 2.94 | 0.8212 | 42.26 | 46.94 | 5.59 | 1.13 | 11.20 | -- | 0.0004 | 0.00 | 4.64 | 17.41 | 413.17 | 82.20 | 10.18 | -- |
| Clearpoint Neuro Inc | 30.43m | -18.15m | 302.33m | 107.00 | -- | 10.43 | -- | 9.94 | -0.6912 | -0.6912 | 1.16 | 1.05 | 0.7242 | 1.50 | 9.66 | 284,383.20 | -43.19 | -34.75 | -51.20 | -39.67 | 60.38 | 64.75 | -59.64 | -76.91 | 3.61 | -- | 0.00 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Delcath Systems Inc | 22.64m | -34.12m | 307.91m | 76.00 | -- | 31.48 | -- | 13.60 | -1.36 | -1.36 | 0.8343 | 0.3059 | 0.5714 | 0.9094 | 6.34 | 297,947.40 | -86.11 | -116.57 | -156.17 | -243.21 | 81.31 | 71.02 | -150.70 | -1,235.37 | 1.03 | -172.60 | 0.1892 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
| Cerus Corp | 197.91m | -19.73m | 308.29m | 288.00 | -- | 5.76 | -- | 1.56 | -0.1076 | -0.1076 | 1.08 | 0.2882 | 1.00 | 1.97 | 7.88 | 687,194.40 | -10.01 | -25.99 | -15.26 | -40.62 | 60.52 | 61.90 | -10.00 | -35.81 | 1.92 | -1.19 | 0.6057 | -- | -0.8061 | 19.69 | 12.37 | -- | 32.07 | -- |
| CVRx Inc | 47.26m | -58.48m | 328.04m | 200.00 | -- | 5.02 | -- | 6.94 | -2.71 | -2.71 | 2.19 | 2.69 | 0.4038 | 0.657 | 6.14 | 236,275.00 | -49.96 | -- | -54.21 | -- | 84.16 | -- | -123.75 | -- | 10.23 | -17.04 | 0.4302 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Nano-X Imaging Ltd | 10.13m | -57.47m | 344.55m | 164.00 | -- | 1.97 | -- | 34.02 | -0.9974 | -0.9974 | 0.1755 | 2.99 | 0.0482 | -- | 6.89 | 61,756.10 | -27.33 | -30.98 | -29.96 | -35.10 | -81.80 | -- | -567.41 | -1,527.24 | 5.09 | -- | 0.0181 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| MaxCyte Inc | 45.60m | -35.74m | 368.13m | 143.00 | -- | 1.72 | -- | 8.07 | -0.3420 | -0.3420 | 0.4368 | 2.03 | 0.177 | 0.5576 | 7.17 | 318,878.30 | -13.87 | -13.18 | -14.86 | -14.33 | 85.98 | 88.79 | -78.37 | -62.96 | 9.22 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| ZimVie Inc | 451.30m | -47.73m | 372.31m | 2.60k | -- | 0.9152 | -- | 0.825 | -1.77 | -13.16 | 16.60 | 14.74 | 0.394 | 1.14 | 4.04 | 173,575.00 | -4.17 | -- | -4.81 | -- | 63.18 | 65.51 | -10.58 | -8.73 | 1.38 | -0.6264 | 0.3514 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Tactile Systems Technology Inc | 285.05m | 15.45m | 373.39m | 992.00 | 24.20 | 1.80 | 16.86 | 1.31 | 0.643 | 0.643 | 11.91 | 8.66 | 0.9812 | 6.20 | 6.80 | 287,349.80 | 5.32 | 0.9015 | 6.20 | 1.09 | 51.44 | 49.10 | 5.42 | 0.8309 | 3.80 | -- | 0.1146 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Alpha Teknova Inc | 36.35m | -31.68m | 412.57m | 210.00 | -- | 4.73 | -- | 11.35 | -0.7366 | -0.7366 | 0.834 | 1.64 | 0.2770 | 3.12 | 7.44 | 173,081.00 | -24.14 | -- | -25.92 | -- | 17.71 | -- | -87.17 | -- | 3.94 | -75.86 | 0.133 | -- | -11.43 | -- | 22.52 | -- | -- | -- |
| Quanterix Corp | 129.33m | -39.71m | 422.94m | 441.00 | -- | 1.26 | -- | 3.27 | -1.04 | -1.04 | 3.40 | 8.77 | 0.3078 | 2.37 | 4.60 | 293,265.30 | -9.45 | -15.96 | -10.30 | -17.66 | 57.42 | 52.79 | -30.71 | -53.79 | 8.99 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
| Semler Scientific Inc | 58.94m | 15.91m | 430.67m | 92.00 | 28.92 | 4.94 | 26.02 | 7.31 | 2.05 | 2.05 | 7.58 | 11.99 | 0.6868 | 17.20 | 9.33 | 640,619.60 | 18.54 | 38.83 | 20.37 | 44.41 | 88.05 | 90.22 | 27.00 | 32.58 | 3.09 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Pacific Biosciences of California Inc | 173.15m | -394.24m | 468.75m | 796.00 | -- | 1.04 | -- | 2.71 | -1.46 | -1.46 | 0.64 | 1.65 | 0.1034 | 1.97 | 5.78 | 217,521.40 | -23.55 | -16.19 | -25.40 | -17.81 | 23.81 | 37.35 | -227.69 | -136.21 | 8.64 | -21.87 | 0.6634 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Treace Medical Concepts Inc | 202.86m | -61.52m | 497.13m | 516.00 | -- | 4.74 | -- | 2.45 | -0.9924 | -0.9924 | 3.27 | 1.68 | 0.8951 | 1.08 | 8.25 | 393,141.50 | -27.15 | -- | -32.22 | -- | 80.61 | -- | -30.33 | -- | 2.98 | -- | 0.3366 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| SI-Bone Inc | 157.04m | -37.40m | 509.55m | 344.00 | -- | 3.08 | -- | 3.24 | -0.9108 | -0.9108 | 3.82 | 3.95 | 0.6859 | 1.46 | 7.00 | 456,497.10 | -16.34 | -27.88 | -18.08 | -30.94 | 77.70 | 85.03 | -23.82 | -51.09 | 7.22 | -- | 0.1799 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Mesa Laboratories Inc | 228.38m | -245.65m | 535.48m | 736.00 | -- | 3.31 | -- | 2.34 | -45.57 | -45.57 | 42.13 | 29.79 | 0.4186 | 2.74 | 5.96 | 310,298.90 | -45.02 | -9.20 | -54.70 | -9.88 | 62.47 | 60.60 | -107.56 | -28.33 | 0.5106 | 1.35 | 0.5594 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
Data as of Nov 21 2024. Currency figures normalised to Alpha Teknova Inc's reporting currency: US Dollar USD
8.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Balyasny Asset Management LPas of 30 Sep 2024 | 1.00m | 1.88% |
| Millennium Management LLCas of 30 Sep 2024 | 737.22k | 1.38% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 557.50k | 1.05% |
| Roubaix Capital LLCas of 30 Sep 2024 | 416.42k | 0.78% |
| Schonfeld Strategic Advisors LLCas of 30 Sep 2024 | 366.40k | 0.69% |
| Point72 Asset Management LPas of 30 Sep 2024 | 308.37k | 0.58% |
| Conestoga Capital Advisors LLCas of 30 Sep 2024 | 305.13k | 0.57% |
| Parkman Healthcare Partners LLCas of 30 Sep 2024 | 251.03k | 0.47% |
| Bank of America, NA (Private Banking)as of 30 Sep 2024 | 216.32k | 0.41% |
| Geode Capital Management LLCas of 30 Sep 2024 | 188.17k | 0.35% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
